Adjuvant chemotherapy not beneficial for patients with luminal A subtype of breast ca

[News]

Premenopausal women whose invasive breast cancers were of the luminal A subtype had comparable 10-year disease-free survival rates regardless of whether or not they received adjuvant chemotherapy, according to data from the phase III DBCG77B clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12.

More... (http://www.news-medical.net/news/20151211/Adjuvant-chemotherapy-not-beneficial-for-patients-with-luminal-A-subtype-of-breast-cancer.aspx)